B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

BLM

MOLECULAR TARGET

BLM RecQ like helicase

UniProt: P54132NCBI Gene: 64119 compounds

BLM (BLM RecQ like helicase) is targeted by 19 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting BLM

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Aurintricarboxylic Acid1.795
2Daunorubicin1.393
3Luteolin 5,7,3',4'-tetrahydroxy-flavone,1.102
4myricetin-3-O-galactopyranoside [Supplementary Concept]1.102
5Quercetin1.102
6Estramustine1.102
7Idarubicin1.102
8juglone hydroxylase [Supplementary Concept] catalyzes1.102
9DEAD-box RNA Helicases0.691
10Thioctic Acid0.691
11Methylene Blue0.691
12Rosmarinic Acid0.691
13Dihydroxyphenylalanine0.691
14Levodopa0.691
15Vitamin K 30.691
16Methyldopa0.691
17Norepinephrine Precursor of epinephrine that is secreted by0.691
18streptonigrin0.691
19Thioctic Acid0.691

About BLM as a Drug Target

BLM (BLM RecQ like helicase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 19 compounds with documented BLM interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

BLM inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.